| Literature DB >> 32508452 |
Bhagirathi D Lakkam1, Madhusudan Astekar2, Shakir Alam2, Gaurav Sapra2, Ashutosh Agarwal2, Aditi Murari Agarwal2.
Abstract
CONTEXT: Focal fibrous hyperplasia, peripheral ossifying fibroma, pyogenic granuloma, peripheral giant cell granuloma, giant cell fibroma and focal reactive overgrowth (FROGs) are one of the foremost numerous benign soft-tissue growths in the oral cavity. Chronic irritation or trauma is with identified as the causative aspect. It may develop up to few centimeters in diameter, pedunculated or sessile and may arise on the gingiva or buccal mucosa. Treatment involves surgical excision, and recurrences are infrequent. AIMS: The aim of this study was to assess the prevalence of FROGs of oral mucosa in an institutional setup. SUBJECTS AND METHODS: All the histopathologically diagnosed cases of FROGs within a period of 10 years (January 2008-December 2017) were retrieved from the archives of the Department of Oral Pathology. The information such as age, sex, site, anatomical side and its prevalence were recorded on customized case history performa. STATISTICAL ANALYSIS USED: The significance of difference was assessed using the Chi-square test and Fisher's exact test.Entities:
Keywords: Fibroma; hyperplasia; lobular capillary hemangioma; oral mucosa; pyogenic granuloma; tumor
Year: 2020 PMID: 32508452 PMCID: PMC7269285 DOI: 10.4103/jomfp.JOMFP_350_19
Source DB: PubMed Journal: J Oral Maxillofac Pathol ISSN: 0973-029X
The master chart showing the prevalence of focal reactive overgrowths of oral mucosa since 2008 till 2017
| Year-wise distribution | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | Total (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cases | 201 | 213 | 171 | 267 | 236 | 256 | 412 | 454 | 303 | 336 | 2849 (100) |
| Focal reactive overgrowths | 39 | 37 | 30 | 24 | 22 | 40 | 78 | 65 | 32 | 82 | 449 (16) |
| Focal fibrous hyperplasia | 28 | 33 | 16 | 13 | 15 | 25 | 59 | 46 | 6 | 36 | 277 (62) |
| Peripheral ossifying fibroma | 3 | 2 | 10 | 8 | 1 | 3 | 0 | 6 | 8 | 4 | 45 (10) |
| Pyogenic granuloma | 3 | 2 | 4 | 2 | 4 | 7 | 9 | 11 | 12 | 38 | 92 (20) |
| Peripheral giant cell granuloma | 5 | 0 | 0 | 1 | 0 | 5 | 10 | 2 | 6 | 4 | 33 (7.5) |
| Giant cell fibroma | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 2 (0.5) |
Age-wise distribution of focal reactive overgrowths of oral mucosa
| Focal reactive overgrowths | Age group (years) | ||||
|---|---|---|---|---|---|
| 0-20 (%) | 21-40 (%) | 41-60 (%) | 61-80 (%) | ||
| Focal fibrous hyperplasia | 55 (20) | 127 (46) | 59 (21) | 36 (13) | <0.001 (significant) |
| Peripheral ossifying fibroma | 19 (42) | 21 (47) | 3 (7) | 2 (4) | <0.001 (significant) |
| Pyogenic granuloma | 33 (36) | 40 (43) | 17 (19) | 2 (2) | <0.001 (significant) |
| Peripheral giant cell granuloma | 3 (10) | 21 (64) | 5 (16) | 4 (13) | <0.001 (significant) |
| Giant cell fibroma | - | 1 (50) | 1 (50) | - | - |
| Total | 110 (24) | 210 (47) | 85 (19) | 44 (10) | |
Gender-wise distribution of focal reactive overgrowths of oral mucosa
| Focal reactive overgrowths | Male (%) | Female (%) | |
|---|---|---|---|
| Focal fibrous hyperplasia | 132 (48) | 145 (52) | 0.6714 (nonsignificant) |
| Peripheral ossifying fibroma | 17 (38) | 28 (62) | <0.001 (significant) |
| Pyogenic granuloma | 13 (39) | 20 (61) | <0.001 (significant) |
| Peripheral giant cell granuloma | 31 (34) | 61 (66) | <0.001 (significant) |
| Giant cell fibroma | 2 (100) | 0 (0) | - |
| Total | 195 (43) | 254 (57) |
Site-wise distribution of focal reactive overgrowths of oral mucosa
| Focal reactive overgrowths | Site | ||||
|---|---|---|---|---|---|
| Buccal mucosa (%) | Gingiva (%) | Palate (%) | Total (%) | ||
| Fibroma | 61 (22) | 188 (68) | 28 (10) | 277 (100) | 0.001* |
| Peripheral ossifying fibroma | 0 (0) | 24 (53) | 21 (47) | 45 (100) | 0.002* |
| Peripheral giant cell granuloma | 0 (0) | 30 (90) | 3 (10) | 33 (100) | 0.336# |
| Pyogenic granuloma | 8 (9) | 75 (82) | 9 (9) | 92 (100) | 0.088# |
| Giant cell fibroma | 0 | 2 (100) | 0 | 2 (100) | - |
*Denoted for significant value, #Denoted for non-significant value
Side-wise distribution of focal reactive overgrowths of oral mucosa
| Focal reactive overgrowth | Anatomical side | ||||
|---|---|---|---|---|---|
| Left (%) | Right (%) | Midline (%) | Total (%) | ||
| Fibroma | 61 (22) | 188 (68) | 28 (10) | 277 (100) | <0.001 (significant) |
| Peripheral ossifying fibroma | 5 (11) | 16 (36) | 24 (53) | 45 (100) | 0.0023 (significant) |
| Pyogenic granuloma | 29 (32) | 40 (43) | 23 (25) | 92 (100) | 0.0889 (nonsignificant) |
| Peripheral giant cell granuloma | 9 (27) | 9 (27) | 15 (46) | 33 (100) | 0.3362 (nonsignificant) |
| Giant cell fibroma | 2 (100) | 0 | 0 | 2 (100) | - |
Literature review showing year-wise distribution of focal reactive overgrowths of oral mucosa
| Authors | Year | Study duration | Study period (years) | Sample size (%) | Lesions | ||||
|---|---|---|---|---|---|---|---|---|---|
| FFH (%) | POF (%) | PG (%) | PGCG (%) | GCF (%) | |||||
| Kfir | 1980 | 1968-1978 | 11 | 741 (64) | 414 (56)* | 78 (11) | 199 (27) | 50 (7)+ | - |
| Stablein | 1985 | 1978-1983 | 6 | 460 (55) | 163 (35) | 74 (16) | 197 (43)* | 26 (6)+ | |
| Zarei | 2007 | 2000-2005 | 5 | 111 (32) | 21 (19) | 18 (16)+ | 40 (36)* | 32 (29) | |
| Buchner | 2010 | 1989-2008 | 20 | 1675 (7) | 532 (32)* | 341 (29) | 488 (29) | 314 (19)+ | - |
| Effiom | 2011 | 1970-2008 | 38 | 314 (6) | 61 (19) | 64 (20) | 179 (57)* | 10 (3)+ | - |
| Naderi | 2012 | 1988-2005 | 17 | 1276 (61) | 288 (14)+ | - | 365 (18) | 623 (30)* | - |
| Reddy | 2012 | 2001-2010 | 10 | 209 (13) | 120 (57)* | 37 (18) | 39 (19) | 13 (6)+ | - |
| Kadeh | 2015 | 2006-2012 | 7 | 154 (34) | 91 (20)* | 11 (12)+ | 37 (41) | 15 (17) | - |
| Kashyap | 2018 | 1.5 years | 1.5 | 67% | 35% | 18% | 42%* | 10%+ | - |
| Present study | 2018 | 2008-2017 | 10 | 449 (15) | 277 (62) | 45 (10) | 92 (20) | 33 (7.5) | 2 (0.5) |
*The most common lesion, +The least common lesion. FFH: Focal fibrous hyperplasia, POF: Peripheral ossifying fibroma, PGCG: Peripheral giant cell granuloma, PG: Pyogenic granuloma, GDF: Giant cell fibroma